V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10138617 | 10054856 | 1.58 | 100 | Neo-adjuvant (N) | 2016-07-14 | 2016-08-28 | Avelumab | 02 | N | FLUOROURACIL + OXALIPLATIN | 101005405 |
| 10140465 | 10054858 | 1.5 | 57.1 | 03 | 2018-09-03 | 2018-09-03 | Avelumab | 02 | N | AVELUMAB | 100642987 |
| 10140587 | 10054859 | 1.79 | 50 | null | 2021-04-04 | 2021-07-14 | CEMIPLIMAB | 02 | null | CEMIPLIMAB | 101591233 |
| 10141993 | 10054860 | 1.61 | 77.1 | null | 2019-01-30 | 2019-02-13 | Avelumab | 02 | null | TRASTUZUMAB | 100468665 |
| 10142947 | 10054861 | 1.57 | 90 | null | null | 2020-01-27 | BENDAMUSTINE + RITUXIMAB | N | null | BENDAMUSTINE + RITUXIMAB | 101324926 |
| 10143751 | 10054862 | 1.83 | 79.8 | 03 | 2020-11-16 | 2020-12-07 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100323751 |
| 10144018 | 10054863 | 1.49 | 60 | Adjuvant (A) | 2020-07-10 | 2020-07-11 | BENDAMUSTINE + RITUXIMAB | 02 | N | BENDAMUSTINE + RITUXIMAB | 101026683 |
| 10145200 | 10054865 | 1.63 | 76.6 | null | 2016-03-30 | 2017-04-21 | NIVOLUMAB | 02 | null | NIVOLUMAB | 101485495 |
| 10146407 | 10054866 | 1.79 | 53.25 | Adjuvant (A) | 2020-09-23 | 2020-10-20 | DARATUMUMAB | 02 | null | DARATUMUMAB | 100737526 |
| 10153052 | 10054869 | 1.72 | 69.3 | null | 2019-12-18 | 2020-05-11 | Avelumab | 02 | null | CARBOPLATIN + GEMCITABINE | 100733124 |
| 10153131 | 10054870 | 1.67 | 94.65 | 03 | 2021-10-14 | 2021-12-24 | NIVOLUMAB | N | N | NIVOLUMAB | 101642586 |
| 10153291 | 10054871 | 1.7 | 71.25 | 03 | 2016-03-31 | 2016-04-23 | Venetoclax | 02 | N | VENETOCLAX | 100982627 |
| 10153982 | 10054872 | 1.72 | 69.7 | Adjuvant (A) | null | 2020-01-14 | Capecitabine + Oxaliplatin 21day | N | N | CAPECITABINE + OXALIPLATIN | 101385317 |
| 10154257 | 10054873 | 1.77 | 45.8 | Palliative (P) | 2021-09-08 | 2021-09-09 | Avelumab | 02 | N | VENETOCLAX | 100391765 |
| 10155000 | 10054874 | 1.65 | 61 | null | 2018-07-17 | 2018-07-31 | CEMIPLIMAB | 02 | null | CEMIPLIMAB | 100177792 |
| 10155365 | 10054875 | 1.84 | 74.5 | null | 2018-06-30 | 2018-08-08 | RUXOLITINIB | N | null | RUXOLITINIB | 100597987 |
| 10155819 | 10054876 | 1.75 | 84.9 | null | 2022-05-24 | 2022-05-25 | DARATUMUMAB | 02 | null | DARATUMUMAB | 100553665 |
| 10155920 | 10054877 | 1.79 | 79 | Palliative (P) | 2022-03-20 | 2022-03-28 | Irinotecan + Modified De Gramont | 02 | null | FLUOROURACIL + IRINOTECAN | 101503057 |
| 10156279 | 10054879 | 1.58 | 72.4 | Adjuvant (A) | 2019-05-17 | 2019-05-20 | Avelumab | 02 | null | TRASTUZUMAB | 100321772 |
| 10156826 | 10054880 | 1.6 | 64.6 | null | 2019-10-23 | 2019-10-30 | Venetoclax | 02 | null | VENETOCLAX | 101098055 |
| 10158411 | 10054881 | 1.63 | 91.3 | null | 2017-03-19 | 2017-03-19 | DARATUMUMAB | 02 | null | DARATUMUMAB | 101659045 |
| 10160697 | 10054882 | 0 | 58.2 | Neo-adjuvant (N) | 2021-07-19 | 2022-02-05 | CAPECITABINE + OXALIPLATIN | null | N | CAPECITABINE + OXALIPLATIN | 101089540 |
| 10160724 | 10054883 | 1.57 | 69.8 | Adjuvant (A) | null | 2021-01-11 | DARATUMUMAB | 02 | N | DARATUMUMAB | 100220231 |
| 10161709 | 10054885 | 1.62 | 71 | null | 2017-05-04 | 2020-01-06 | Avelumab | null | null | BENDAMUSTINE + RITUXIMAB | 100645879 |
| 10162341 | 10054886 | 1.61 | 107.3 | 03 | 2017-03-01 | 2017-03-15 | Trastuzumab | 02 | N | TRASTUZUMAB | 101235343 |
| 10162790 | 10054887 | 1.77 | 72.5 | null | 2021-04-05 | 2021-04-15 | DARATUMUMAB | 02 | null | DARATUMUMAB | 101648758 |
| 10162796 | 10054888 | 1.67 | 82.5 | Disease modification (D) | 2021-11-06 | 2021-11-06 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 100570563 |
| 10164254 | 10054891 | 1.49 | 151.2 | null | null | 2020-07-31 | Venetoclax | 02 | null | VENETOCLAX | 101460626 |
| 10165850 | 10054892 | 1.74 | 51 | Palliative (P) | 2019-12-13 | 2019-12-31 | Irinotecan + Modified De Gramont | 02 | N | FLUOROURACIL + IRINOTECAN | 101204501 |
| 10165998 | 10054893 | 1.55 | 79.4 | null | 2020-03-26 | 2020-03-31 | GEMCARBO | 02 | null | CARBOPLATIN + GEMCITABINE | 100005330 |
| 10168334 | 10054895 | 1.69 | 90.5 | null | 2020-02-24 | 2020-09-05 | Avelumab | null | null | NIVOLUMAB | 101071948 |
| 10168630 | 10054896 | 1.66 | 96.3 | 03 | 2021-03-14 | 2022-02-19 | RUXOLITINIB | 02 | N | RUXOLITINIB | 100214267 |
| 10168862 | 10054897 | 1.64 | 94.4 | null | 2022-05-05 | 2022-05-16 | CAPECITABINE + OXALIPLATIN | null | null | CAPECITABINE + OXALIPLATIN | 101247974 |
| 10169424 | 10054898 | 1.79 | 67 | null | 2015-12-02 | 2016-09-07 | RUXOLITINIB | 02 | null | RUXOLITINIB | 100660211 |
| 10170001 | 10054899 | null | 86 | null | 2019-12-17 | 2019-12-28 | CEMIPLIMAB | 02 | N | CEMIPLIMAB | 101077469 |
| 10170480 | 10054900 | 1.64 | 0 | null | 2018-04-04 | 2018-04-04 | CEMIPLIMAB | null | null | CEMIPLIMAB | 100805252 |
| 10170642 | 10054901 | 1.83 | 62.8 | Neo-adjuvant (N) | 2016-09-25 | 2016-10-09 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100453122 |
| 10170837 | 10054902 | 1.66 | 56.2 | null | null | 2017-08-28 | CEMIPLIMAB | 02 | null | CEMIPLIMAB | 101050963 |
| 10172489 | 10054904 | null | 0 | null | 2019-08-03 | 2019-08-06 | DARATUMUMAB | 02 | null | DARATUMUMAB | 100806076 |
| 10173154 | 10054906 | null | 73.3 | null | 2019-04-22 | 2019-04-22 | Avelumab | 02 | null | FLUOROURACIL + OXALIPLATIN | 100549958 |
| 10173560 | 10054907 | 1.63 | 58.2 | null | 2017-01-27 | 2017-01-27 | GEMCARBO | 02 | null | CARBOPLATIN + GEMCITABINE | 100508516 |
| 10173655 | 10054908 | 1.74 | 73.5 | null | 2020-01-17 | 2020-01-27 | RUXOLITINIB | 02 | null | RUXOLITINIB | 101284343 |
| 10174651 | 10054909 | 1.5 | 53.15 | null | null | 2020-11-09 | CEMIPLIMAB | null | null | CEMIPLIMAB | 100952841 |
| 10175211 | 10054910 | 1.61 | null | null | 2013-04-30 | 2020-05-05 | FLUOROURACIL + IRINOTECAN | 02 | null | FLUOROURACIL + IRINOTECAN | 100551804 |
| 10176151 | 10054911 | 1.81 | 66 | Adjuvant (A) | 2019-02-22 | 2019-04-12 | Avelumab | 02 | null | FLUOROURACIL + OXALIPLATIN | 101107491 |
| 10176800 | 10054912 | 1.7 | 87.6 | Palliative (P) | null | 2019-05-24 | Avelumab | 02 | N | CEMIPLIMAB | 100693276 |
| 10178801 | 10054913 | 1.67 | 89.5 | Palliative (P) | null | 2022-03-12 | Avelumab | 01 | N | VENETOCLAX | 100545570 |
| 10180375 | 10054914 | 1.69 | 71.3 | Palliative (P) | 2018-05-06 | 2018-08-22 | Avelumab | 02 | N | DARATUMUMAB | 100642351 |
| 10180920 | 10054915 | 1.75 | 81.8 | Disease modification (D) | 2021-10-27 | 2021-11-05 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101670481 |
| 10182350 | 10054916 | 1.9 | 86.1 | null | 2020-10-26 | 2020-11-12 | GemCarbo Days 1+8 | 02 | null | CARBOPLATIN + GEMCITABINE | 101321036 |